D
Douglas Twenefour
Researcher at Diabetes UK
Publications - 11
Citations - 877
Douglas Twenefour is an academic researcher from Diabetes UK. The author has contributed to research in topics: Medicine & Stigma (botany). The author has an hindex of 4, co-authored 11 publications receiving 411 citations.
Papers
More filters
Journal ArticleDOI
Joint international consensus statement for ending stigma of obesity.
Francesco Rubino,Francesco Rubino,Rebecca M. Puhl,David E. Cummings,Robert H. Eckel,Donna H. Ryan,Jeffrey I. Mechanick,Jeffrey I. Mechanick,Joe Nadglowski,Ximena Ramos Salas,Phillip R. Schauer,Douglas Twenefour,Caroline M. Apovian,Caroline M. Apovian,Louis J. Aronne,Rachel L. Batterham,Rachel L. Batterham,Hans Rudolph Berthoud,Camilo Boza,Luca Busetto,Dror Dicker,Mary de Groot,Dan Eisenberg,Stuart W. Flint,Terry T.-K. Huang,Lee M. Kaplan,John P. Kirwan,Judith Korner,Theodore K. Kyle,Blandine Laferrère,Carel W. le Roux,La Shawn McIver,Geltrude Mingrone,Geltrude Mingrone,Patricia M. Nece,Tirissa J. Reid,Ann M. Rogers,Michael Rosenbaum,Randy J. Seeley,Antonio J. Torres,John B. Dixon +40 more
TL;DR: In this paper, a multidisciplinary group of international experts, including representatives of scientific organizations, reviewed available evidence on the causes and harms of weight stigma and, using a modified Delphi process, developed a joint consensus statement with recommendations to eliminate weight bias.
Journal ArticleDOI
Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes.
Pamela Dyson,Douglas Twenefour,Cathy Breen,Alistair Duncan,E Elvin,Louise M Goff,Alyson Hill,P Kalsi,N Marsland,Paul McCardle,Duane Mellor,Lindsay Oliver,K Watson +12 more
TL;DR: These 2018 guidelines emphasize a flexible, individualized approach to diabetes management and weight loss and highlight the emerging evidence for remission of Type 2 diabetes.
Journal ArticleDOI
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes.
Matthew C. Riddle,William T. Cefalu,Philip Evans,Hertzel C. Gerstein,Michael A. Nauck,William Oh,Amy E. Rothberg,Carel W. le Roux,Francesco Rubino,Philip R. Schauer,Roy Taylor,Douglas Twenefour +11 more
TL;DR: In this article, an international expert group was convened by the American Diabetes Association to propose nomenclature and principles for data collection and analysis, with the goal of establishing a base of information to support future clinical guidance.
Journal ArticleDOI
Consensus report: definition and interpretation of remission in type 2 diabetes
Matthew C. Riddle,William T. Cefalu,Philip Evans,Hertzel C. Gerstein,Michael A. Nauck,William Oh,Amy E. Rothberg,Carel W. le Roux,Francesco Rubino,Philip R. Schauer,Roy Taylor,Douglas Twenefour +11 more
TL;DR: In this paper, an international expert group was convened by the American Diabetes Association to propose nomenclature and principles for data collection and analysis, with the goal of establishing a base of information to support future clinical guidance.
Journal ArticleDOI
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes.
Matthew C. Riddle,William T. Cefalu,Philip Evans,Hertzel C. Gerstein,Michael A. Nauck,William Oh,Amy E. Rothberg,Carel W. le Roux,Francesco Rubino,Philip R. Schauer,Roy Taylor,Douglas Twenefour +11 more
TL;DR: An international expert group was convened by the American Diabetes Association to propose nomenclature and principles for data collection and analysis, and "remission" was proposed as the most appropriate descriptive term, and HbA1c < 6.5% measured at least 3 months after cessation of glucose-lowering pharmacotherapy as the usual diagnostic criterion.